Table 2. SpeB activity phenotype correlates with GAS disease.
Columbia agar with skim milk a | C-broth agar with casein (extrapolated values) c | |||||||
---|---|---|---|---|---|---|---|---|
Disease group | No. of SpeB- producers | No. of SpeB- non-producers | % SpeB- non-producers | p value, pharyngitis versus b: | No. of SpeB- producers | No. of SpeB-non-producers | % SpeB- non-producers | p value, pharyngitis versus b: |
Pharyngitis | 116 | 30 | 20.5 | n/a | 106 | 32 | 23.7 | n/a |
Impetigo | 69 | 4 | 5.5 | 0.0029 | 69 | 4 | 5.5 | 0.0009 |
Invasive | 50 | 10 | 16.7 | N.S. | 44 | 12 | 21.4 | N.S. |
ARF | 24 | 17 | 41.5 | 0.0085 | 20 | 20 | 50.0 | 0.0016 |
a One ARF and one impetigo isolate had intermediate ("weak") zones of clearance on Columbia-SM agar (S1 Table), and are excluded from the calculations.
b Fisher's exact test, 2-tailed; N.S., non-significant.
c Data extrapolations for the complete set of GAS organisms are made for impetigo and pharyngitis isolates (italics). Organisms with intermediate ("weak") zones of clearance on CBrothMg-C agar (S1 Table) are excluded from the calculations.